GSK plc
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. […]
Read More
RSV vaccine from GSK shows potential to protect adults 50 to 59
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, a disease that causes thousands of hospitalizations and deaths […]
Read More
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
Artur Widak | Nurphoto | Getty Images Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial in adults ages 50 and above this year after showing positive results in an early to mid-stage study. The biotech company hopes its shot, mRNA-1083, can win approval from […]
Read More
Covid, RSV and flu vaccines are now available — here’s how to decide whether to get them together
Pharmacist Ani Martirosyan administers an immunization to a patient at a CVS on Tuesday, Sept. 12, 2023 in Glendale, CA. Brian Van Der Brug | Los Angeles Times | Getty Images For the first time ever, vaccines for Covid, the flu and respiratory syncytial virus are available in the U.S. Public health officials are urging […]
Read More
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
A nurse prepares a flu shot at Huntington Village Pediatrics, in Huntington, New York on December 8, 2021. Steve Pfost | Newsday | Getty Images Moderna on Wednesday said its experimental mRNA-based flu vaccine produced a stronger immune response against four strains of the virus than a currently available flu vaccine in a late-stage trial, […]
Read More
Covid vaccine rollout begins early in the United kingdom with new variant under enjoy
Covid-19 vaccination centre at a Chemist shop on 28th April 2023 in London, United Kingdom. Mike Kemp | In Shots | Getty Photos LONDON — England on Monday began its wintertime Covid-19 and flu vaccination marketing campaign forward of plan as it screens a new variant and seeks to prevent an additional “twindemic” straining the […]
Read More
These 10 medications are likely targets for Medicare price negotiations this fall
Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the program’s nearly six-decade history. The Centers for Medicare […]
Read More
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine. GSK claims Pfizer’s RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen used in its own shot. related investing news “Upon information and belief, Pfizer knowingly […]
Read More
Europe shares shut reduce as German economic climate stagnates Lender of Japan surprises with coverage tweak
European stocks closed a little decrease Friday as buyers processed a week of earnings and central bank decisions. Resource
Read More
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Budrul Chukrut | Lightrocket | Getty Images GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will drive future sales. “I think the uptake on this we need […]
Read More